Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
6 hedge funds and large institutions have $17.6M invested in Aravive, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$15.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.38M |
| 3 |
VM
VHCP Management
New York
|
+$578K |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$228K |
| 5 |
TCM
Tygh Capital Management
Portland,
Oregon
|
+$228K |
Top Sellers
ARAV Hedge Fund Activity: Q1 2014 in Review
6 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2014, worth a combined $17.6M.
Buyers outnumbered sellers: 6 funds opened new ARAV positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $15.3M.
- 6 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2014, up from 0 in Q4 2013.
- Funds reported $17.6M of Aravive, Inc. Common Stock stock for Q1 2014.
- 6 funds opened new Aravive, Inc. Common Stock positions in Q1 2014 and 0 closed out, a net change of +6 holders.
- The largest Aravive, Inc. Common Stock buyer in Q1 2014 was Perceptive Advisors, an estimated $15.3M added.
Based on aggregated 13F filings for Q1 2014.